Exploring potential working mechanisms of accelerated HF-rTMS in refractory major depression with a focus on locus coeruleus connectivity

This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression...

Full description

Saved in:
Bibliographic Details
Published inEuropean psychiatry Vol. 67; no. 1; p. e70
Main Authors Wu, Guo-Rong, Baeken, Chris
Format Journal Article
LanguageEnglish
Published England Cambridge University Press 17.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD). We studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain's noradrenergic system and key to mood regulation and stress response. A stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response. The findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum's role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.
AbstractList Abstract Background This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD). Methods We studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain’s noradrenergic system and key to mood regulation and stress response. Results A stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response. Conclusions The findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum’s role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.
This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD). We studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain's noradrenergic system and key to mood regulation and stress response. A stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response. The findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum's role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.
This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD).BACKGROUNDThis study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD).We studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain's noradrenergic system and key to mood regulation and stress response.METHODSWe studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain's noradrenergic system and key to mood regulation and stress response.A stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response.RESULTSA stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response.The findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum's role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.CONCLUSIONSThe findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum's role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.
BackgroundThis study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD).MethodsWe studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain’s noradrenergic system and key to mood regulation and stress response.ResultsA stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response.ConclusionsThe findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum’s role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.
ArticleNumber e70
Author Wu, Guo-Rong
Baeken, Chris
AuthorAffiliation 2 Ghent Experimental Psychiatry (GHEP) Lab, Ghent University , Ghent , Belgium
3 Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University , Ghent , Belgium
4 Vrije Universiteit Brussel (VUB), Department of Psychiatry, University Hospital (UZBrussel) , Brussels , Belgium
5 Department of Electrical Engineering, Eindhoven University of Technology Eindhoven , The Netherlands
1 Key Laboratory of Cognition and Personality, Faculty of Psychology, Southwest University , Chongqing , China
AuthorAffiliation_xml – name: 2 Ghent Experimental Psychiatry (GHEP) Lab, Ghent University , Ghent , Belgium
– name: 1 Key Laboratory of Cognition and Personality, Faculty of Psychology, Southwest University , Chongqing , China
– name: 3 Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University , Ghent , Belgium
– name: 5 Department of Electrical Engineering, Eindhoven University of Technology Eindhoven , The Netherlands
– name: 4 Vrije Universiteit Brussel (VUB), Department of Psychiatry, University Hospital (UZBrussel) , Brussels , Belgium
Author_xml – sequence: 1
  givenname: Guo-Rong
  surname: Wu
  fullname: Wu, Guo-Rong
– sequence: 2
  givenname: Chris
  orcidid: 0000-0001-9885-3041
  surname: Baeken
  fullname: Baeken, Chris
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39417327$$D View this record in MEDLINE/PubMed
BookMark eNp9ksFu1DAQhiNURLeFF-CALHHpJYsdO7F9QqhqaaUiDpSz5XUmuw6JvdhOyz4Cb42z2yLaAyePxv98Hs_8J8WR8w6K4i3BS0Jk9aFfwhS2cbescMWWhDfyRbEgnIuS1qI-KhZYVqyUlIrj4iTGHmPCMW5eFcdUMsJpxRfF74tf28EH69Zo6xO4ZPWA7n34MWdGMBvtbBwj8h3SxsAAQSdo0dVlGW6_fEPWoQBd0Cb5sEOj7n1ALWwDxGi9Q_c2bZBGnTdTRjg07APjIUwD7CPnwCR7Z9PudfGy00OENw_nafH98uL2_Kq8-fr5-vzTTWmY5KkUqxYD17Vk2vBVVdfEdJIwwUDj_CsgsgEpqTRCYFOTpuYEN9LwrqINpQboaXF94LZe92ob7KjDTnlt1T7hw1rpkKwZQEkpcNU1wLiYX2Cy7YBi3BHRrgiWbWZ9PLC202qE1uT5BT08gT69cXaj1v5OkTx-jGuRCWcPhOB_ThCTGm3Mcx60Az9FRbOyIUzWVZa-fybt_RRcntWsEpJVFM-qd_-29LeXx5VngTgITPAx5u0pY5NOeV25QzsogtXsLtWrg7vU7C41uyuXVs9KH-n_KfoDHpHXXg
CitedBy_id crossref_primary_10_1038_s41398_024_03171_9
crossref_primary_10_1016_j_bpsc_2025_02_010
Cites_doi 10.1016/j.nicl.2022.103049
10.1111/j.2044-8260.1967.tb00530.x
10.31887/DCNS.2011.13.1/cbaeken
10.1038/s41467-021-22509-1
10.1016/j.physbeh.2023.114231
10.3109/15622975.2013.872295
10.1152/jn.00677.2020
10.1097/HRP.0000000000000364
10.4103/1673-5374.235019
10.1002/hbm.26510
10.1016/j.clinph.2017.06.243
10.1038/s41592-018-0235-4
10.1007/s00702-015-1374-8
10.1016/j.neuroimage.2018.05.070
10.1007/s12311-021-01300-4
10.1002/hbm.25244
10.1016/j.neuroimage.2021.118591
10.1097/NEN.0b013e3182588293
10.1093/brain/awx379
10.1007/s13167-017-0112-8
10.1007/s00406-023-01637-3
10.1038/s41467-021-21943-5
10.1002/hbm.24935
10.1038/s41380-022-01806-1
10.3389/fpsyt.2020.601519
10.1038/s41598-017-09077-5
10.1016/j.brs.2023.03.009
10.1016/j.neures.2023.04.004
10.5498/wjp.v10.i10.223
ContentType Journal Article
Copyright The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024 The Author(s)
Copyright_xml – notice: The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024 The Author(s)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1192/j.eurpsy.2024.1769
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ - Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1778-3585
ExternalDocumentID oai_doaj_org_article_99802f6e478148449dfe300f18db109d
PMC11730058
39417327
10_1192_j_eurpsy_2024_1769
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
09C
09E
0R~
1B1
1P~
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8FI
8FJ
8P~
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AANRG
AAOAW
AAQXK
AASVR
AAXUO
AAYWO
AAYXX
ABBQC
ABBZL
ABFNM
ABGDZ
ABIVO
ABJNI
ABMZM
ABUWG
ABVKB
ABWVN
ABXAU
ABXDB
ABXHF
ACAJB
ACDAQ
ACDLN
ACGFS
ACHQT
ACIUM
ACQPF
ACRPL
ACVFH
ACZWT
ADAZD
ADBBV
ADCNI
ADDNB
ADEZE
ADKIL
ADMUD
ADNMO
ADOVH
ADVJH
ADVLN
AEBAK
AEKER
AENCP
AENEX
AEUPX
AEVXI
AEYHU
AFCTW
AFKRA
AFPKN
AFPUW
AFRHN
AFTJW
AFZFC
AGABE
AGHFR
AGJUD
AGQPQ
AGUBO
AGYEJ
AHIPN
AHRGI
AIGII
AITUG
AJPFC
AJRQY
AJUYK
AKBMS
AKMAY
AKRWK
AKYEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANZVX
AQJOH
ASPBG
AVWKF
AZFZN
AZQEC
BENPR
BLXMC
BLZWO
CCPQU
CCQAD
CCUQV
CFBFF
CGQII
CITATION
CJCSC
CS3
DOHLZ
DU5
DWQXO
EBS
EGQIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYUFA
G-Q
GBLVA
GNUQQ
GROUPED_DOAJ
HVGLF
HZ~
IHE
IKXGN
IOO
IPYYG
J1W
LN9
M2M
M41
MO0
N9A
NZEOI
O-L
O9-
OAUVE
OH0
OK1
OU-
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PIMPY
PSYQQ
Q38
R2-
RCA
RIG
ROL
RPM
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
UHS
UKHRP
UV1
WFFJZ
Z5R
~G-
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c497t-8bd0e7a594ac7b2551cf91484ea0941e196e9939c880c516571069c7f23633ce3
IEDL.DBID DOA
ISSN 0924-9338
1778-3585
IngestDate Wed Aug 27 01:23:44 EDT 2025
Thu Aug 21 18:28:32 EDT 2025
Fri Jul 11 02:20:56 EDT 2025
Mon Jun 30 15:12:07 EDT 2025
Mon Jul 21 05:39:44 EDT 2025
Tue Jul 01 02:17:42 EDT 2025
Thu Apr 24 23:00:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords major depressive disorder
locus coeruleus
accelerated rTMS
Language English
License http://creativecommons.org/licenses/by/4.0
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c497t-8bd0e7a594ac7b2551cf91484ea0941e196e9939c880c516571069c7f23633ce3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9885-3041
OpenAccessLink https://doaj.org/article/99802f6e478148449dfe300f18db109d
PMID 39417327
PQID 3118942302
PQPubID 4933639
ParticipantIDs doaj_primary_oai_doaj_org_article_99802f6e478148449dfe300f18db109d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11730058
proquest_miscellaneous_3117614952
proquest_journals_3118942302
pubmed_primary_39417327
crossref_citationtrail_10_1192_j_eurpsy_2024_1769
crossref_primary_10_1192_j_eurpsy_2024_1769
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-17
PublicationDateYYYYMMDD 2024-10-17
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-17
  day: 17
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Paris
– name: Cambridge, UK
PublicationTitle European psychiatry
PublicationTitleAlternate Eur Psychiatry
PublicationYear 2024
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
References S0924933824017693_r27
S0924933824017693_r26
S0924933824017693_r29
S0924933824017693_r28
Seki (S0924933824017693_r7) 2018; 13
S0924933824017693_r23
S0924933824017693_r22
S0924933824017693_r25
S0924933824017693_r21
S0924933824017693_r20
Klooster (S0924933824017693_r24) 2022; 7
S0924933824017693_r19
S0924933824017693_r16
S0924933824017693_r15
S0924933824017693_r18
S0924933824017693_r17
S0924933824017693_r12
S0924933824017693_r11
S0924933824017693_r14
S0924933824017693_r13
S0924933824017693_r1
S0924933824017693_r30
S0924933824017693_r10
S0924933824017693_r3
S0924933824017693_r2
S0924933824017693_r5
S0924933824017693_r4
S0924933824017693_r6
S0924933824017693_r9
S0924933824017693_r8
References_xml – ident: S0924933824017693_r6
  doi: 10.1016/j.nicl.2022.103049
– ident: S0924933824017693_r11
  doi: 10.1111/j.2044-8260.1967.tb00530.x
– ident: S0924933824017693_r5
  doi: 10.31887/DCNS.2011.13.1/cbaeken
– ident: S0924933824017693_r8
  doi: 10.1038/s41467-021-22509-1
– ident: S0924933824017693_r28
  doi: 10.1016/j.physbeh.2023.114231
– ident: S0924933824017693_r10
  doi: 10.3109/15622975.2013.872295
– ident: S0924933824017693_r20
  doi: 10.1152/jn.00677.2020
– ident: S0924933824017693_r1
  doi: 10.1097/HRP.0000000000000364
– volume: 13
  start-page: 1159
  year: 2018
  ident: S0924933824017693_r7
  article-title: Molecular mechanism of noradrenaline during the stress-induced major depressive disorder
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.235019
– volume: 7
  start-page: 536
  year: 2022
  ident: S0924933824017693_r24
  article-title: Personalizing repetitive transcranial magnetic stimulation parameters for depression treatment using multimodal neuroimaging
  publication-title: Biol Psychiatry Cogn Neurosci Neuroimaging
– ident: S0924933824017693_r18
  doi: 10.1002/hbm.26510
– ident: S0924933824017693_r27
  doi: 10.1016/j.clinph.2017.06.243
– ident: S0924933824017693_r13
  doi: 10.1038/s41592-018-0235-4
– ident: S0924933824017693_r29
  doi: 10.1007/s00702-015-1374-8
– ident: S0924933824017693_r17
  doi: 10.1016/j.neuroimage.2018.05.070
– ident: S0924933824017693_r22
  doi: 10.1007/s12311-021-01300-4
– ident: S0924933824017693_r16
  doi: 10.1002/hbm.25244
– ident: S0924933824017693_r14
  doi: 10.1016/j.neuroimage.2021.118591
– ident: S0924933824017693_r15
  doi: 10.1097/NEN.0b013e3182588293
– ident: S0924933824017693_r2
  doi: 10.1093/brain/awx379
– ident: S0924933824017693_r25
  doi: 10.1007/s13167-017-0112-8
– ident: S0924933824017693_r23
  doi: 10.1007/s00406-023-01637-3
– ident: S0924933824017693_r26
  doi: 10.1038/s41467-021-21943-5
– ident: S0924933824017693_r30
  doi: 10.1002/hbm.24935
– ident: S0924933824017693_r4
  doi: 10.1038/s41380-022-01806-1
– ident: S0924933824017693_r21
  doi: 10.3389/fpsyt.2020.601519
– ident: S0924933824017693_r9
  doi: 10.1038/s41598-017-09077-5
– ident: S0924933824017693_r12
  doi: 10.1016/j.brs.2023.03.009
– ident: S0924933824017693_r19
  doi: 10.1016/j.neures.2023.04.004
– ident: S0924933824017693_r3
  doi: 10.5498/wjp.v10.i10.223
SSID ssj0017006
Score 2.42164
Snippet This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral...
BackgroundThis study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left...
Abstract Background This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e70
SubjectTerms accelerated rTMS
Adult
Antidepressants
Brain research
Brain-derived neurotrophic factor
Clinical outcomes
Depressive Disorder, Major - physiopathology
Depressive Disorder, Major - therapy
Depressive Disorder, Treatment-Resistant - physiopathology
Depressive Disorder, Treatment-Resistant - therapy
Dorsolateral Prefrontal Cortex
Drug therapy
Electric fields
Electroconvulsive therapy
Female
Humans
locus coeruleus
Locus Coeruleus - physiopathology
Magnetic Resonance Imaging
major depressive disorder
Male
Mental depression
Middle Aged
Neurobiology
Neurogenesis
Prefrontal Cortex - physiopathology
Psychotropic drugs
Transcranial Magnetic Stimulation - methods
Treatment Outcome
Title Exploring potential working mechanisms of accelerated HF-rTMS in refractory major depression with a focus on locus coeruleus connectivity
URI https://www.ncbi.nlm.nih.gov/pubmed/39417327
https://www.proquest.com/docview/3118942302
https://www.proquest.com/docview/3117614952
https://pubmed.ncbi.nlm.nih.gov/PMC11730058
https://doaj.org/article/99802f6e478148449dfe300f18db109d
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fa9swEBejD2MvY__nri0a7G14lSzZsh7bshAG2cta6JuRZImlJHZwEkY_wr5172THJGVsL3sT9lnIpzvd_aTTHSGftM9DrQuX2tLYVHoNrQDqrn3wos4ViA3eHZ59L6Y38tttfrtX6gtjwvr0wD3jzgEOsCwUHq9EylJKXUMnjAVe1pYzXePqCzZvB6aG8wPFYlVNBugiBche7q7L6Oz8DjMqrtb3gA0z-YUrDHXeM0kxc_-f3M3HUZN7Zmjygjwf_Ed60Y_7JXnim1fk6Ww4IX9Nfo9BdXTVbjAUCKh_9TvidOnxnu98vVzTNlDjHNgcTBVR0-kk7a5nP-i8oTC-LhbhuadLc9d2dAyWbSju2lJDQ-u20EVDF7HhWt9tFz62YNl2fUGKN-Rm8vX6apoO5RZSJ7XapKWtmVcm19I4ZQFqcBc08twbwIDcg6568Ga0A5V3OS9ycE4K7VTIRCGE8-ItOWraxr8nFJZRHgph0P-UmRSWOSeshfXDaAs9JoTvOF65IRc5lsRYVBGT6AwwST9LFc5ShbOUkM_jN6s-E8dfqS9xIkdKzKIdH4BsVYNsVf-SrYSc7MSgGlR7XQmAZPBTgmUJ-Ti-BqXEkxbT-HYbaVSB2BNo3vVSM45EAC-VyFRCygN5Ohjq4Ztm_jMm_oZesbpAefw_fu4DeYbcQjvM1Qk52nRbfwoO1saeRV06iztfD6aDJc0
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+potential+working+mechanisms+of+accelerated+HF-rTMS+in+refractory+major+depression+with+a+focus+on+locus+coeruleus+connectivity&rft.jtitle=European+psychiatry&rft.au=Guo-Rong%2C+Wu&rft.au=Baeken%2C+Chris&rft.date=2024-10-17&rft.pub=Cambridge+University+Press&rft.issn=0924-9338&rft.eissn=1778-3585&rft.volume=67&rft.issue=1&rft_id=info:doi/10.1192%2Fj.eurpsy.2024.1769&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0924-9338&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0924-9338&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0924-9338&client=summon